Skip to main content
. 2015 Apr 25;4(1):89–105. doi: 10.1007/s40122-015-0035-9

Table 8.

Time to task completion for NAI and NXN

Summary Phase 1 Phase 3 Comparison of NAI or NXN between phasesb
Total participants (n) 42 42
NAI total time to complete critical tasks (min)a
 N 42 42 <0.0001
 Mean (SD) 0.9 (0.25) 0.5 (0.15)
 Median 0.9 0.5
 Min, Max 0.5, 1.5 0.3, 0.9
NXN total time to complete critical tasks (min)a
 N 42 42 <0.0001
 Mean (SD) 6.0 (4.76) 2.0 (2.15)
 Median 3.6 1.6
 Min, Max 1.8, 15.0 0.8, 15.0
Comparison of NAI and NXN within each phaseb <0.0001 <0.0001

NAI naloxone 0.4 mg auto-injector, NXN naloxone nasal atomization kit

aSubject not completing the task counted as 15 min

bWilcoxon rank-sum test performed as sensitivity analysis